These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33482392)

  • 1. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway.
    Wang F; Zhang Y; Shen J; Yang B; Dai W; Yan J; Maimouni S; Daguplo HQ; Coppola S; Gao Y; Wang Y; Du Z; Peng K; Liu H; Zhang Q; Tang F; Wang P; Gao S; Wang Y; Ding WX; Guo G; Wang F; Zong WX
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1369-1385. PubMed ID: 33482392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Fever with Thrombocytopenia Syndrome Virus NSs Interacts with TRIM21 To Activate the p62-Keap1-Nrf2 Pathway.
    Choi Y; Jiang Z; Shin WJ; Jung JU
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis.
    Pan JA; Sun Y; Jiang YP; Bott AJ; Jaber N; Dou Z; Yang B; Chen JS; Catanzaro JM; Du C; Ding WX; Diaz-Meco MT; Moscat J; Ozato K; Lin RZ; Zong WX
    Mol Cell; 2016 Mar; 61(5):720-733. PubMed ID: 26942676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin.
    Hou K; Shen J; Yan J; Zhai C; Zhang J; Pan JA; Zhang Y; Jiang Y; Wang Y; Lin RZ; Cong H; Gao S; Zong WX
    EBioMedicine; 2021 Jul; 69():103456. PubMed ID: 34233258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
    Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding.
    Feng X; Jiang T; Yang C; Pang S; Ding Z; Hu H; Wang H; Dong L; Yang N
    Cell Death Dis; 2021 Dec; 13(1):6. PubMed ID: 34921137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
    Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.
    Tan CT; Chang HC; Zhou Q; Yu C; Fu NY; Sabapathy K; Yu VC
    EMBO Rep; 2021 Jan; 22(1):e50854. PubMed ID: 33393215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway.
    Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C
    Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.
    Zhao L; Kang M; Liu X; Wang Z; Wang Y; Chen H; Liu W; Liu S; Li B; Li C; Chang A; Tang B
    J Exp Clin Cancer Res; 2022 Nov; 41(1):330. PubMed ID: 36419136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
    Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo.
    Guerrero-Escalera D; Alarcón-Sánchez BR; Arellanes-Robledo J; Cruz-Rangel A; Del Pozo-Yauner L; Chagoya de Sánchez V; Resendis-Antonio O; Villa-Treviño S; Torres-Mena JE; Pérez-Carreón JI
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119222. PubMed ID: 35093454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.
    Mattu S; Zavattari P; Kowalik MA; Serra M; Sulas P; Pal R; Puliga E; Sutti S; Foglia B; Parola M; Albano E; Giordano S; Perra A; Columbano A
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):113-127. PubMed ID: 34530178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
    Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
    J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinoma.
    Bartolini D; Stabile AM; Migni A; Gurrado F; Lioci G; De Franco F; Mandarano M; Svegliati-Baroni G; Di Cristina M; Bellezza G; Rende M; Galli F
    Arch Biochem Biophys; 2024 Jul; 757():110043. PubMed ID: 38789086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
    Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
    Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers.
    Ding Q; He D; He K; Zhang Q; Tang M; Dai J; Lv H; Wang X; Xiang G; Yu H
    Tumour Biol; 2015 Nov; 36(11):8761-72. PubMed ID: 26055142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lu J; Ding Y; Zhang W; Qi Y; Zhou J; Xu N; Zhang Y; Xie W
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.